PPARG and myeloid sarcoma: To determine whether MS alleviates airway inflammation and reduces viral load via PPARγ activation, we compared the effects of HMS with the PPARγ agonist pioglitazone, as well as HMS combined with the PPARγ inhibitor GW9662, in H1N1-infected mice.